Predicting relapse in ductal carcinoma in situ patients: an analysis of biologic markers with long-term follow-up
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference10 articles.
1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007
2. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up;Sanders;Cancer,2005
3. Ductal carcinoma in situ of the breast;Burstein;N Engl J Med,2004
4. Ductal carcinoma in situ: a review of recent advances;Tang;Curr Opin Obstet Gynecol,2007
5. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17;Fisher;Cancer,1995
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma in situ;Frontiers in Oncology;2023-05-19
2. Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies;Modern Pathology;2019-02-13
3. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast;Cancer Treatment Reviews;2017-04
4. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS);The Breast;2017-02
5. Ductal carcinomain situ- update on risk assessment and management;Histopathology;2015-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3